Publte reporting burden (or this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and to the Office of Management and Budget,, Washington, DC 20503
AGENCY USE ONLY (Leave blank)
REPORT DATE October 20003. REPORT TYPE AND DATES COVERED Final (15 Sep 9? -14 Sep_00)
TITLE AND SUBTITLE
Transcriptional Regulation of BRCAl
AUTHOR(S)Shannon R. Payne, Ph.D. Mary Claire King, Ph.D.
FUNDING NUMBERS
DAMD17-97-1-7210
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES)University of Washington Seattle, Washington 98105-6613
E-MAIL:spayne@u.washington, edu 8. PERFORMING ORGANIZATION REPORT NUMBER Germline mutations in BRCAl lead to an increased risk of breast and ovarian cancer, with loss of the second, normal allele critical to tumorigenesis. It was widely presumed that the cloning and characterization of genes involved in hereditary breast cancer would lead to a better understanding of the genesis of the more common non-inherited forms of breast cancer. The relative lack of somatic mutations found in BRCAl, however, has argued against its involvement in non-inherited breast cancer. Our research specifically addresses whether large genomic rearrangements are responsible for somatic inactivation of BRCAl. We characterized the types of large germline rearrangements that occur within the BRCAl region and investigated the contribution of two large germline rearrangements to breast cancer in a population-based series of breast cancer patients. In order to determine whether BRCAl is inactivated somatically by large rearrangement of BRCAl, we analyzed 92 breast carcinomas using loss of heterozygosity analysis, Long PCR, Southern analysis, and immunohistochemistry. Although two large germline rearrangements were detected in our series, no large somatic rearrangements were identified. As previously reported BRCAl protein was reduced in the majority of breast tumors of high histologic grade. Interestingly, reduced BRCAl protein in sporadic breast carcinomas was significantly associated with loss of the most 5' BRCAl intragenic marker.
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES)U14. SUBJECT TERMS In Family 5, previous analysis of cDNA revealed germline deletion of exon 3 (codon 27 stop), cosegregating with 10 cases of breast and ovarian cancer (Friedman et al., 1994. Nat Genet., 8:399); the genomic basis of the mRNA deletion remained unknown. Long-range PCR, using an exon 3 forward/"exon 4" reverse primer pair designed from BRCA1 genomic sequence (gb L78833), reveals a 1039 bp genomic deletion involving part of exon 3 and pa...